Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IGFBPL1 Antikörper (AA 201-278)

IGFBPL1 Reaktivität: Human ELISA, IF (cc), IF (p), IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1714840
  • Target Alle IGFBPL1 Produkte
    IGFBPL1 (Insulin-Like Growth Factor Binding Protein-Like 1 (IGFBPL1))
    Bindungsspezifität
    • 14
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 201-278
    Reaktivität
    • 27
    • 9
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 25
    • 3
    Kaninchen
    Klonalität
    • 28
    Polyklonal
    Konjugat
    • 6
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser IGFBPL1 Antikörper ist unkonjugiert
    Applikation
    • 12
    • 12
    • 7
    • 5
    • 2
    • 2
    • 2
    ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Homologie
    Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human IGFBPL1
    Isotyp
    IgG
  • Applikationshinweise
    ELISA 1:500-1000
    IHC-P 1:200-400
    IHC-F 1:100-500
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Haltbarkeit
    12 months
  • Liu, Zhang, He, Yang, Wang, Zhang, Guo: "Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling." in: Clinical epigenetics, Vol. 12, Issue 1, pp. 22, (2021) (PubMed).

  • Target
    IGFBPL1 (Insulin-Like Growth Factor Binding Protein-Like 1 (IGFBPL1))
    Andere Bezeichnung
    IGFBPL1 (IGFBPL1 Produkte)
    Synonyme
    IGFBP-RP4 antikoerper, IGFBPRP4 antikoerper, bA113O24.1 antikoerper, 2810011G06Rik antikoerper, 2810453O06Rik antikoerper, IGFBPL antikoerper, insulin like growth factor binding protein like 1 antikoerper, insulin-like growth factor binding protein-like 1 antikoerper, IGFBPL1 antikoerper, Igfbpl1 antikoerper
    Hintergrund

    Synonyms: bA113O24.1, IGFBP-related protein 10, IGFBP-RP4, IGFBPRP4, insulin-like growth factor binding protein related protein 4, insulin-like growth factor-binding protein-like 1, IBPL1_HUMAN, insulin-like growth factor-binding-related protein 4.

    Background: IGFBPL1 is a secreted IGF (Insulin-like growth factor) binding protein that is known to contain an Ig-like C2-type (immunoglobulin-like) domain, an IGFBP N-terminal domain and a Kazal-like domain. IGF-binding proteins characteristically act to extend the half-life of IGFs and may influence the growth promoting effects of the IGFs. The interaction of IGFBPs with IGFs can affect cell surface receptors, specifically, IGFBPs may enhance or decrease a cells insulin sensitivity. IGFBPL1 has been found to be down-regulated in multiple tumors and thus may be a likely tumor suppressor candidate. Highly expressed in both brain and testis, IGFBPL1 is found at lower levels in the prostate, bladder and lung.

Sie sind hier:
Kundenservice